Stockscreener 앱 받기
1.09
29.92%
0.2356
전일 마감가:
$0.8544
열려 있는:
$1.08
하루 거래량:
70.22M
Relative Volume:
51.38
시가총액:
$6.46M
수익:
-
순이익/손실:
$-15.52M
주가수익비율:
-0.0587
EPS:
-18.58
순현금흐름:
$-16.61M
1주 성능:
+16.97%
1개월 성능:
+29.07%
6개월 성능:
-64.08%
1년 성능:
-78.49%
1일 변동 폭
$1.02
$1.45
1주일 범위
$0.7066
$1.45
52주 변동 폭
$0.702
$4.872
Revelation Biosciences Inc Stock (REVB) Company Profile
명칭
Revelation Biosciences Inc
전화
650-800-3717
주소
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
REVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.0901 | 5.06M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.98 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.28 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.85 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.53 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.87 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Revelation Biosciences Inc 주식(REVB)의 최신 뉴스
Revelation Biosciences Gains Momentum as FDA Agreement Sparks Hope - StocksToTrade
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus (UPDATED) - Benzinga
Revelation Biosciences (REVB) Secures FDA Agreement for Gemini Drug's Clinical Trial Pathway - Intellectia AI
Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours? - Benzinga
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - citizen-times.com
Revelation Biosciences reaches FDA agreement on AKI treatment pathway By Investing.com - Investing.com Nigeria
Revelation Biosciences Reaches FDA Agreement on Gemini for AKI - TradingView — Track All Markets
Targets Report: What is Revelation Biosciences Inc. Equity Warrant’s valuation compared to sectorWeekly Trade Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - USA Today
Revelation Biosciences reaches FDA agreement on AKI treatment pathway - Investing.com
Upcoming EventsRevelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - FinancialContent
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - delawareonline.com
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - newportri.com
Will Revelation Biosciences Inc. Equity Warrant benefit from green energy policiesDay Trading Setups & Free Unlock Rapid Growth Potential - bollywoodhelpline.com
Will Revelation Biosciences Inc. Equity Warrant be affected by tariffsDollar Strength & Low Drawdown Investment Ideas - bollywoodhelpline.com
How Revelation Biosciences Inc. stock trades before earningsMarket Trend Report & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Treasury Yields: Is PLYA likely to announce a buybackJuly 2025 Spike Watch & AI Driven Price Forecasts - baoquankhu1.vn
Revelation Biosciences (REVB) to Present Kidney Disease Treatment Data at Conference - Intellectia AI
Revelation Bio To Share New Data From PRIME Study Of Gemini In March - Nasdaq
EPS Watch: Will ZBAI stock recover after earningsGlobal Markets & Weekly High Return Opportunities - baoquankhu1.vn
Breakout Zone: Can Revelation Biosciences Inc lead its sector in growth2025 Market Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn
Whittier Daily News - FinancialContent
New kidney study to show how Gemini may help acute injury patients - Stock Titan
Aug Opening: What risks investors should watch in Revelation Biosciences Inc Equity Warrant stock - Bộ Nội Vụ
Wall Street Recap: Can Revelation Biosciences Inc beat the S P 500Weekly Trade Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Earnings Recap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesEarnings Summary Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Biotech recruits new employee with 90,000 stock units over 2 years - Stock Titan
Revelation Biosciences Inc (REVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.39%
1.96%
자본화:
|
볼륨(24시간):